Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer
Mohamed S. Hasim(Ottawa Hospital Research Institute), Jim Dimitroulakos(Ottawa Hospital Research Institute)
Cited by 31
Related Papers
Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells
|PLoS ONE|2012|48
Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
|PLoS ONE|2010|32
Lovastatin‐induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal
|International Journal of Cancer|2013|25
Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
|Cancer Cell International|2010|24
The Role of Activating Transcription Factor 3 as a Regulator of DNA-Damaging Chemotherapy Cytotoxicity
|uO Research (University of Ottawa)|2019|0